BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/20/2015 9:10:00 PM | Browse: 1242 | Download: 1261
 |
Received |
|
2014-06-29 14:16 |
|
Peer-Review Started |
|
2014-06-29 21:42 |
|
To Make the First Decision |
|
2014-08-06 17:25 |
|
Return for Revision |
|
2014-08-15 16:47 |
|
Revised |
|
2014-08-31 00:10 |
|
Second Decision |
|
2014-11-27 13:18 |
|
Accepted by Journal Editor-in-Chief |
|
2014-11-27 18:32 |
|
Accepted by Executive Editor-in-Chief |
|
2014-12-08 16:01 |
|
Articles in Press |
|
2014-12-08 17:06 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2014-12-21 18:01 |
|
Typeset the Manuscript |
|
2015-01-06 12:08 |
|
Publish the Manuscript Online |
|
2015-01-20 20:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Minireviews |
| Article Title |
Recent advances in the prevention of Hepatitis B recurrence after liver transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zhi-Feng Xi and Qiang Xia |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Shanghai Jiaotong University School of Medicine Science and Technology Fund |
11XJ21016 |
| Training Program for Super Academic Leaders in the Shanghai Health System |
XBR2011029 |
|
| Corresponding Author |
Qiang Xia, Professor, Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, No. 160 Pujian Road, Shanghai 200127, China. xiaqiang@medmail.com.cn |
| Key Words |
Liver transplantation; Hepatitis B recurrence; Hepatitis B immunoglobulin; Lamivudine; Entecavir; Tenofovir |
| Core Tip |
The strategy of hepatitis B immunoglobulin (HBIG) combined with lamivudine has been the standard treatment for the prophylaxis of hepatitis B virus recurrence after liver transplantation. However, the high resistance rate of lamivudine and the many disadvantages of HBIG have compelled surgeons to reconsider the long-term efficacy of this strategy for the prevention of hepatitis B reinfection. This review discusses new strategies for prophylaxis of the recurrence of hepatitis B after liver transplantation.
|
| Publish Date |
2015-01-20 20:12 |
| Citation |
Xi ZF, Xia Q. Recent advances in prevention of hepatitis B recurrence after liver transplantation. World J Gastroenterol 2015; 21(3): 829-835 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i3/829.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i3.829 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
